CPH 0.00% 0.9¢ creso pharma limited

Ann: Preliminary Final Report, page-6

  1. 429 Posts.
    lightbulb Created with Sketch. 64
    Lol, they might as well raise right now before the SP plunges even further. Massive dilution in CY20, and making a huge loss to produce the paltry income. Management ought to hang their heads in shame, but no doubt they will inform us of the "huge pipeline of sales opportunities", in hopes of pumping the price before another CR. More dilution, more handouts to incompetent management, and a SP going backwards at a rate of knots.
    Disgraceful greed exhibited by a useless management team.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.